Journal article

Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the Irbesartan Diabetic Nephropathy Trial: Clinical implications and limitations

MA Pohl, S Blumenthal, DJ Cordonnier, F De Alvaro, G DeFerrari, G Eisner, E Esmatjes, RE Gilbert, LG Hunsicker, JBL de Faria, R Mangili, J Moore, E Reisin, E Ritz, G Schernthaner, S Spitalewitz, H Tindall, RA Rodby, EJ Lewis

Journal of the American Society of Nephrology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2005